This test helps doctors figure out your blood type. It also checks if your blood is compatible with blood from another person. This is important before giving someone blood, like during surgery or if they are sick.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Blood grouping and crossmatching are the laboratory tests that make a blood transfusion safe. Blood grouping, also called blood typing, identifies your ABO type (the main blood group system, named for the A and B markers on red cells, which sorts blood into type A, B, AB or O) and your Rh factor, a protein on red blood cells that makes your type positive or negative. Crossmatching goes one step further: the lab tests your blood against a specific donor unit to confirm your body will not attack it. These tests matter because your immune system carries antibodies against the blood group markers your own red cells lack. Someone with type A blood, for example, has antibodies against type B. If mismatched red cells are transfused, those antibodies can destroy them and cause a serious reaction. Alongside typing, the lab usually runs an antibody screen, which looks for less common antibodies a person can develop after an earlier transfusion or pregnancy. Routine A, B and Rh typing does not detect these, so the screen and crossmatch catch mismatches that matching the type alone would miss. The tests are ordered before a planned or likely transfusion, including before many surgeries; hospitals often set in advance which operations need a sample tested and how much blood to hold ready. A type and screen checks your type and looks for antibodies without reserving blood. A type and crossmatch also sets aside matched units for you. Blood typing on its own is also routine early in pregnancy and when people donate blood.
For most people no preparation is needed, and there is no fasting. The most useful thing you can do is give the care team a full history: earlier transfusions, pregnancies (including miscarriages), transplants, any past transfusion reaction and any blood antibody you have been told you carry. Each of these can affect how long it takes to find compatible blood. If you are being treated with daratumumab (Darzalex or Darzalex Faspro), an antibody medicine used for multiple myeloma, make sure the team and the blood bank know. It does not change your ABO or Rh type, but it interferes with the antibody screen for up to six months after the last dose, so the blood bank needs extra steps. The prescribing information advises doing a type and screen before the first dose.
The test itself is an ordinary blood draw from a vein, usually in the arm, and takes only a few minutes. You may feel a brief sting. Because a sample from the wrong person could lead to incompatible blood, staff confirm who you are carefully before labeling the tube. This can feel repetitive, but it is deliberate. In the lab, your red cells are mixed with antibodies against A, B and Rh to see which ones make the cells clump, and the result is confirmed by mixing the liquid part of your blood with known type A and type B cells. The antibody screen checks your plasma for other clinically important antibodies. For a crossmatch, your plasma is tested against cells from the donor unit chosen for you. If the screen finds an antibody, the lab identifies it and looks for donor blood that lacks the matching marker, which can take hours or, in complex cases, days. In an emergency, when bleeding cannot wait, blood can be released before crossmatching is complete. Type O red cells, which carry neither the A nor the B marker, can be given to people of any ABO type in that situation.
You can return to normal activity right away. A little soreness or bruising where the needle went in is common and fades over a few days. Results usually go straight to the care team and the hospital blood bank rather than needing a separate appointment. Your blood type is inherited, but new antibodies can form after a transfusion or pregnancy, so a fresh sample is usually needed before later transfusions even when your type is already on file. If you are pregnant and the result is Rh-negative, your obstetric team will plan around it. Problems arise if the baby is Rh-positive and some of the baby's blood enters your circulation, which can lead your body to make antibodies that attack the red cells of a later Rh-positive baby. An injection of Rh immune globulin (RhoGAM is a familiar brand) prevents those antibodies from forming. It is commonly given around 28 weeks, within 72 hours after delivering an Rh-positive baby, and after events such as miscarriage, bleeding later in pregnancy or an injury to the abdomen. It does not help once antibodies have already formed, which is why an antibody screen is part of prenatal testing.
The test carries the small risks of any blood draw: bruising, a little bleeding, lightheadedness or fainting, and rarely infection at the needle site. Some people need more than one needle stick if veins are hard to find. The more important risks belong to the transfusion the testing protects. Routine typing does not detect every blood group marker, and a reaction can occasionally happen even with matched blood. Because blood is typed, screened and crossmatched, serious reactions from incompatible blood are rare. Most start during or soon after the transfusion, but some appear days later. Fever, chills, back or flank pain, dark or bloody urine, flushing or dizziness during a transfusion should be reported to the nurse at once so the transfusion can be stopped. If fever or dark urine develops in the days after a transfusion, contact the care team that gave it promptly. Having antibodies does not make transfusion unsafe, but it can delay it while compatible blood is found. For someone with known antibodies, testing well before a planned surgery gives the blood bank time.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Blood Grouping and Crossmatching, what to expect, or ask the community a question.